Unicycive Therapeutics CEO Shalabh Gupta's 2021 pay jumps 75% to $1.1M
Unicycive Therapeutics reports 2021 executive compensation
By ExecPay News
Published: April 19, 2022
Unicycive Therapeutics reported fiscal year 2021 executive compensation information on April 19, 2022.
In 2021, three executives at Unicycive Therapeutics received on average a compensation package of $665K, a 109% increase compared to previous year.
Average pay of disclosed executives at Unicycive Therapeutics
Shalabh Gupta, Chief Executive Officer, received $1.1M in total, which increased by 75% compared to 2020. 60% of Gupta's compensation, or $670K, was in salary. Gupta also received $124K in bonus and $331K in option awards.
Pramod Gupta, Executive VP Pharmaceutical and Business Operations, received a compensation package of $488K, which increased by 79% compared to previous year. 47% of the compensation package, or $232K, was in option awards.
John Townsend, Chief Financial Officer, earned $383K in 2021, a 864% increase compared to previous year.
Related executives
You may also like
Source: SEC filing on April 19, 2022.